4-(3-Nitro-pyridin-2-yloxy)-piperidine-1-carboxylicacidtert-butylester
97%
- Product Code: 219575
CAS:
1065484-06-1
Molecular Weight: | 323.344 g./mol | Molecular Formula: | C₁₅H₂₁N₃O₅ |
---|---|---|---|
EC Number: | MDL Number: | MFCD09877660 | |
Melting Point: | Boiling Point: | 442.0±45.0 °C(Predicted) | |
Density: | 1.247 g/cm3 | Storage Condition: | Room temperature, seal, dry |
Product Description:
Used as an intermediate in pharmaceutical synthesis, particularly in the development of kinase inhibitors and other biologically active compounds. Its structure supports the construction of complex molecules with potential activity in oncology and inflammatory diseases. The tert-butyl ester group allows for selective deprotection, enabling stepwise synthesis in multi-stage drug manufacturing. Commonly employed in medicinal chemistry for modifying solubility and bioavailability during lead optimization.
Sizes / Availability / Pricing:
Size | Availability | Price | Quantity |
---|---|---|---|
500mg | 10-20 days | ฿29,360.00 |
+
-
|
4-(3-Nitro-pyridin-2-yloxy)-piperidine-1-carboxylicacidtert-butylester
Used as an intermediate in pharmaceutical synthesis, particularly in the development of kinase inhibitors and other biologically active compounds. Its structure supports the construction of complex molecules with potential activity in oncology and inflammatory diseases. The tert-butyl ester group allows for selective deprotection, enabling stepwise synthesis in multi-stage drug manufacturing. Commonly employed in medicinal chemistry for modifying solubility and bioavailability during lead optimization.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :